JAMA Cardiology : Effect of Nudges to Clinicians, Patients, or Both to Increase Statin Prescribing
Interview with Mitesh S. Patel, MD, MBA, author of Effect of Nudges to Clinicians, Patients, or Both to Increase Statin Prescribing: A Cluster Randomized Clinical Trial, and Faraz S. Ahmad, MD, MS, author of Nudging to Improve Cardiovascular Care—Clinicians, Patients, or Both. Hosted by Sadiya Sana Khan, MD, MS. Related Content: Effect of Nudges to Clinicians, Patients, or Both to Increase Statin Prescribing Nudging to Improve Cardiovascular Care—Clinicians, Patients, or Both (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - November 30, 2022 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
Diabetes Core Update – December 2022
Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatmen...
Source: Diabetes Core Update - November 25, 2022 Category: Endocrinology Authors: American Diabetes Association Source Type: podcasts
JAMA Neurology : Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease
Interview with Camille Carroll, MD, PhD, author of Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease: A Randomized Clinical Trial. Hosted by Cynthia E. Armand, MD. Related Content: Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - November 1, 2022 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
JAMA Surgery : Clinical Trials Design, Scientific Rigor, and Higher-Level Evidence in Surgery
Interview with Kamal M. F. Itani, MD, author of Clinical Trials Design, Scientific Rigor, and Higher-Level Evidence in Surgery. Hosted by Amalia Cochran, MD. Related Content: Clinical Trials Design, Scientific Rigor, and Higher-Level Evidence in Surgery (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - October 26, 2022 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
JAMA Cardiology : Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control
Interview with Nicholas M. Pajewski, PhD, author of Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control: A Secondary Analysis of a Randomized Clinical Trial, and Daniel W. Jones, MD, author of Blood Pressure Control After SPRINT—Back to Reality. Hosted by Gregg C. Fonarow, MD. Related Content: Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control Blood Pressure Control After SPRINT—Back to Reality (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - October 12, 2022 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
SCCMPod-463 CCM: Clazakizumab for COVID-19: Friend or Foe?
Clazakizumab is a monoclonal antibody against human interleukin-6 that may benefit patients hospitalized with severe or critical COVID-19 accompanied by hyperinflammation. Although not yet FDA approved, clinical trials of clazakizumab for treatment of COVID-19 are under way worldwide. Samantha Gambles Farr, MSN, NP-C, CCRN, RNFA, is joined by Bonnie E. Lonze, MD, PhD, to discuss the article, A Randomized Double-Blinded Placebo Controlled Trial of Clazakizumab for the Treatment of COVID-19 Pneumonia With Hyperinflammation, published in the September 2022 issue of Critical Care Medicine. Dr. Lonze is a faculty transplant sur...
Source: SCCM PodCast - iCritical Care - October 6, 2022 Category: Intensive Care Authors: The Society of Critical Care Medicine (SCCM) Tags: Medicine Source Type: podcasts
Treatment of Peripheral Artery Disease
In this JAMA Author Interview, JAMA Interim Executive Editor Greg Curfman, MD, speaks with Mary M. McDermott, MD, professor of medicine at Northwestern University Feinberg School of Medicine, on current therapies for peripheral artery disease and a new clinical trial she directed on the use of telmisartan, an angiotensin receptor blocker, for patients with peripheral artery disease. Related Content: Effect of Telmisartan on Walking Performance in Patients With Lower Extremity Peripheral Artery Disease (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - October 4, 2022 Category: General Medicine Authors: JAMA Network Source Type: podcasts
JAMA Surgery : Operative vs Nonoperative Treatment of Acute Unstable Chest Wall Injuries
Interview with Niloofar Dehghan, MD, and Michael McKee, MD, authors of Operative vs Nonoperative Treatment of Acute Unstable Chest Wall Injuries: A Randomized Clinical Trial. Hosted by Amalia Cochran, MD. (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - September 22, 2022 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
JAMA Psychiatry : Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder
Interview with Michael P. Bogenschutz, MD, author of Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial. Hosted by John Torous, MD. Related Content: Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - August 24, 2022 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
JAMA Cardiology : Alerting Clinicians to 1-Year Mortality Risk in Patients Hospitalized With Heart Failure
Interview with Tariq Ahmad, MD, MPH, author of Alerting Clinicians to 1-Year Mortality Risk in Patients Hospitalized With Heart Failure: The REVEAL-HF Randomized Clinical Trial, and Rishi K. Wadhera, MD, MPP, MPhil, author of Improving Quality Improvement—From Aspiration Toward Empiricism. Hosted by Gregg C. Fonarow, MD. Related Content: Alerting Clinicians to 1-Year Mortality Risk in Patients Hospitalized With Heart Failure Improving Quality Improvement—From Aspiration Toward Empiricism (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - August 10, 2022 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
FDA warns about possible increased risk of death and serious side effects with cancer drug Copiktra (duvelisib)
Listen to an audio podcast of the June 30, 2022, FDA Drug Safety Communication. Results from a clinical trial show a possible increased risk of death with Copiktra (active ingredient duvelisib) compared to another medicine to treat leukemia and lymphoma. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - July 27, 2022 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
Can Omecamtiv Mecarbil Improve Peak Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction (HFrEF)?
Exercise limitation is a cardinal manifestation of heart failure with reduced ejection fraction (HFrEF), but it is not consistently improved by any of the current guideline-directed medical therapies. JAMA Deputy Editor Gregory Curfman, MD, discusses whether omecamtiv mecarbil can improve peak exercise capacity in patients with HFrEF with Gregory D. Lewis, MD, from Massachusetts General Hospital, and Mark H. Drazner, MD, MSc, from University of Texas Southwestern Medical Center. Related Content: Effect of Omecamtiv Mecarbil on Exercise Capacity in Chronic Heart Failure With Reduced Ejection Fraction: The METEORIC-HF Rando...
Source: JAMA Author Interviews - July 19, 2022 Category: General Medicine Authors: JAMA Network Source Type: podcasts
JAMA Surgery : Intraoperative Urinary Catheter Use and Urinary Retention After Laparoscopic Inguinal Hernia Repair
Interview with Aldo Fafaj, MD, author of Effect of Intraoperative Urinary Catheter Use on Postoperative Urinary Retention After Laparoscopic Inguinal Hernia Repair: A Randomized Clinical Trial.Hosted by Amalia Cochran, MD. (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - June 15, 2022 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
